ArticleHaematologica2026
Outcomes of real-world complete responders after fixed duration glofitamab in relapsed/refractory large B-cell lymphoma.
Abstract read
In one paragraph
Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
58 authors.
Evgenii ShumilovDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster.
Rebecca Wurm-KuczeraDepartment of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin.
Joseph KauerDepartment of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg.
Meng WangDepartment of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin.
Paolo MazzeoDepartment of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany; Department of Hematology and Medical Oncology, INDIGHO Laboratory, University Medical Center Goettingen (UMG), Goettingen.
Hristo BoyadzhievDepartment of Medical Oncology, University Hospital Bern, University of Bern, Bern, Switzerland; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Basel.
Niklas GebauerDepartment for Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck.
Udo HoltickDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne.
Alexander HölscherDepartment of Hematolgy, Oncology and Immunolgy, University Hospital of Duesseldorf, Duesseldorf.
Marcel TeichertDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen.
Paulina Maria NierychlewskaOncohematology Division, IEO European Institute of Oncology IRCCS, Milan.
Christoph KimmichDepartment of Hematology and Oncology, University Hospital Oldenburg, Oldenburg.
Philipp BerningDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster.
Thomas MelchardtIIIrd Medical Department at the Paracelsus Medical University Salzburg, Cancer Center, Salzburg; Salzburg Cancer Research Institute, Salzburg; Austrian Group for Medical Tumor Therapy (AGMT), Salzburg; Cancer Cluster, Salzburg.
Vanja ZeremskiUniversity Hospital Magdeburg, Department of Hematology, Oncology, and Cell Therapy, Magdeburg.
Chiara WirthsDepartment of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen.
Philipp NakovDepartment of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel.
Christian Schultze-FloreyDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover.
Giuliano Filippini VelazquezDepartment of Hematology, University Hospital Augsburg, Augsburg.
Vadim LesanDepartment of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg.
Isabelle KrämerDepartment of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg.
Florian KaiserMVZ Dr. Vehling-Kaiser GmbH, Landshut.
Ursula Vehling-KaiserMVZ Dr. Vehling-Kaiser GmbH, Landshut.
Anna Ossami-SaidyDepartment of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin.
Henriette HuberDepartment of Internal Medicine III, Hospital of Karlsruhe, Karlsruhe.
Akhil BehringerDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster.
Martin BentzDepartment of Internal Medicine III, Hospital of Karlsruhe, Karlsruhe.
Julia Katharina ScholzDepartment of Internal Medicine 5 - Hematology and Oncology, University Hospital of Erlangen, Erlangen.
Philipp GödelDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne.
Ulf SchnetzkeDepartment of Internal Medicine II, Hematology and Medical Oncology, University Hospital Jena, Jena.
Vladan VucinicDepartment of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig.
Elisabeth ShorbDepartment of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg.
Susanne GhandiliDepartment of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg.
Andrea KerkhoffDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster.
Sebastian ScheichGoethe University Frankfurt, University Hospital, Frankfurt am Main.
Semra AydinDepartment of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital of Bonn, Bonn.
Karin MayerDepartment of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital of Bonn, Bonn.
Ulrike BacherDepartment of Hematology, University Hospital Inselspital and University of Bern, Bern.
Kai WilleUniversity Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Minden.
Bertram GlassDepartment of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin.
Thomas OellerichGoethe University Frankfurt, University Hospital, Frankfurt am Main.
Francis AyukDepartment of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg.
Florian HeidelDepartment of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel.
Lorenz ThurnerDepartment of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg.
Mathias LutzDepartment of Hematology, University Hospital Augsburg, Augsburg.
Mathias HänelMedical Clinic III, Klinikum Chemnitz, Chemnitz.
Christian W ScholzDepartment of Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin.
Mareike TomettenDepartment of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen.
Christiane PottDepartment of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel.
Peter DregerDepartment of Hematology and Medical Oncology, INDIGHO Laboratory, University Medical Center Goettingen (UMG), Goettingen.
Dimitrios MougiakakosUniversity Hospital Magdeburg, Department of Hematology, Oncology, and Cell Therapy, Magdeburg.
Sascha DietrichDepartment of Hematolgy, Oncology and Immunolgy, University Hospital of Duesseldorf, Duesseldorf.
Enrico DerenziniOncohematology Division, IEO European Institute of Oncology IRCCS, Milan.
Björn ChapuyDepartment of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium, partner site Berlin, a partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin.
Bastian von TresckowDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen.
Thomas PabstDepartment of Medical Oncology, University Hospital Bern, University of Bern, Bern.
Fabian MüllerDepartment of Internal Medicine 5 - Hematology and Oncology, University Hospital of Erlangen, Erlangen.
Georg LenzDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster. georg.lenz@ukmuenster.de.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.